Chronic rejection of lung allografts: insights from a new experimental model

Srebrena Atanasova, Alena Evers, Gabriele Fuchs, Kathrin Petri, Martin Obert, Andrea Fischer-Heuschkel, Leatitia Rabin, Markus Hirschburger, Daniel Jonigk, Winfried Padberg & Veronika Grau
Introduction: The long term survival of human lung allograft recipients is limited by the development of a fatal Bronchiolitis obliterans syndrome (BOS). Both, chronic allograft rejection and alloantigen independent factors like infections seem to contribute to the pathogenesis of BOS. Relevant experimental[for full text, please go to the a.m. URL]